WebDec 31, 2024 · This press release contains certain forward-looking statements with respect to GENFIT, including those within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding GENFIT’s research and development programs and planned release of financial information. WebGENFIT 885 Avenue Eugène Avinée, 59120 Loos - FRANCE +333 2016 4000 www.genfit.com 1 PRESS RELEASE GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update • Cash and cash equivalents totaled €258.8 million as of December 31, 2024 • Major financial achievements in 2024 include landmark strategic …
GENFIT: Provides Initial Update on Corporate Strategy Nasdaq
WebApr 7, 2024 · Lille, France; Cambridge, MA; April 7, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of … WebJan 24, 2024 · GENFIT annonce son calendrier financier pour 2024. Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 24 janvier 2024 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies du foie dont les besoins … hardware administration
GENFIT to Acquire Clinical-stage Biopharmaceutical
WebDec 17, 2024 · Paris (France), 17 December 2024 – Ipsen (Euronext: IPN; ADR: IPSEY) and GENFIT (Nasdaq and Euronext: GNFT) have entered into a long-term strategic … WebLille (France), Cambridge (Massachusetts, United States), March 10, 2016– GENFIT (Euronext: GNFT – ISIN: FR0004163111), a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announced that it has … WebMay 11, 2024 · This press release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995, with … changemyaddress